Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

188.17
Delayed Data
As of Sep 20
 -1.53 / -0.81%
Today’s Change
133.64
Today|||52-Week Range
191.10
+28.70%
Year-to-Date

Today’s Trading

Previous close188.17
Today’s open188.32
Day’s range186.50 - 188.96
Volume2,082,214
Average volume (3 months)2,981,304
Market cap$137.3B
Dividend yield2.44%
Data as of 4:00pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.82%
Earnings growth (next 5 years)+3.73%
Revenue growth (last year)+6.31%
P/E ratio17.1
Price/Sales4.86
Price/Book4.65

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.02-0.02%
BIIBBiogen-3.97-1.24%
ILMNIllumina Inc-2.85-1.40%
KITEKite Pharma Inc-0.36-0.20%
Data as of 09/21/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts